Nigel W Bunnett

22PUBLICATIONS
81CO-AUTHORS
Molecular targetsAllergyCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromoleculesMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 14, 2026
Neuropilin-1 mediates nerve growth factor signaling of oral cancer pain.

|May 19, 2026
Endosomal signalling of protease-activated receptor-2 amplifies histamine-induced pain of irritable bowel syndrome.

|Jan 27, 2026
EGFR activation sensitizes trigeminal NMDA receptors to promote pain and morphine analgesic tolerance in oral cancer.

Naijiang Liu, Xiaojie Shi, Shao-Rui Chen

|Dec 14, 2025
Critical role of the mast cell/tryptase/PAR2 axis in anastrozole-induced pain.

Maria Fernanda Pessano Fialho, Raquel Tonello, Evelyne Silva Brum

|Oct 07, 2025
Nanomedicines targeting protease-activated receptor 2 in endosomes provide sustained analgesia.

Shavonne L Teng, Rocco Latorre, Divya Bhansali

|Sep 25, 2025
Targeting prostaglandin E2 receptor 2 in Schwann cells inhibits inflammatory pain but not inflammation.

Romina Nassini, Lorenzo Landini, Matilde Marini

Pageof 4

Frequent Collaborators

8 joint publications

Dane Jensen

7 joint publications

Daniel P Poole

6 joint publications

Nicholas Veldhuis

5 joint publications

Rocco Latorre